Telomere length shows no association with BRCA1 and BRCA2 mutation status.
This study aimed to determine whether telomere length (TL) is a marker of cancer risk or genetic status amongst two cohorts of BRCA1 and BRCA2 mutation carriers and controls. The first group was a prospective set of 665 male BRCA1/2 mutation carriers and controls (mean age 53 years), all healthy at...
Saved in:
Main Authors: | Emma Killick, Malgorzata Tymrakiewicz, Clara Cieza-Borrella, Paula Smith, Deborah J Thompson, Karen A Pooley, Doug F Easton, Elizabeth Bancroft, Elizabeth Page, Daniel Leongamornlert, IMPACT collaborators, Zsofia Kote-Jarai, Rosalind A Eeles |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/cdfabafadb5b476489a69b8ed1a6df47 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
by: Kara N. Maxwell, et al.
Published: (2017) -
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
by: Ilirjana Bajrami, et al.
Published: (2021) -
BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage
by: Jekaterina Vohhodina, et al.
Published: (2021) -
BRCA1 and BRCA2mutations in breast cancer patients from Venezuela
by: Lara,Karlena, et al.
Published: (2012) -
Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America
by: Josef S. Herzog, et al.
Published: (2021)